Trials / Completed
CompletedNCT00078793
Registry of Etanercept (Enbrel®) In Children With Juvenile Rheumatoid Arthritis
Phase IV Registry of Etanercept (Enbrel®) In Children With Juvenile Rheumatoid Arthritis
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 600 (actual)
- Sponsor
- Amgen · Industry
- Sex
- All
- Age
- 2 Years – 18 Years
- Healthy volunteers
- Not accepted
Summary
This study will evaluate long-term safety of etanercept with or without other DMARDs in children with polyarticular course or systemic juvenile rheumatoid arthritis (JRA) compared to a cohort of subjects with polyarticular or systemic JRA receiving methotrexate with or without other DMARDs.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Enbrel® | Etanercept alone, etanercept plus methotrexate or other DMARDs |
Timeline
- Start date
- 2000-06-01
- Primary completion
- 2008-01-01
- Completion
- 2008-01-01
- First posted
- 2004-03-09
- Last updated
- 2013-05-14
Source: ClinicalTrials.gov record NCT00078793. Inclusion in this directory is not an endorsement.